TABLE OF CONTENTS
1 INTRODUCTION 53
1.1 OBJECTIVES OF THE STUDY 53
1.2 MARKET DEFINITION 53
1.3 OVERVIEW OF THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET 53
1.4 LIMITATIONS 55
1.5 MARKETS COVERED 55
2 MARKET SEGMENTATION 58
2.1 MARKETS COVERED 58
2.2 GEOGRAPHICAL SCOPE 59
2.3 YEARS CONSIDERED FOR THE STUDY 60
2.4 CURRENCY AND PRICING 60
2.5 DBMR TRIPOD DATA VALIDATION MODEL 61
2.6 MULTIVARIATE MODELLING 64
2.7 PRODUCT LIFELINE CURVE 65
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.9 DBMR MARKET POSITION GRID 67
2.10 MARKET APPLICATION COVERAGE GRID 69
2.11 VENDOR SHARE ANALYSIS 70
2.12 SECONDARY SOURCES 71
2.13 ASSUMPTIONS 71
3 EXECUTIVE SUMMARY 72
4 PREMIUM INSIGHTS 74
4.1 PESTEL ANALYSIS 75
4.2 PORTER'S FIVE FORCES MODEL 76
4.3 SUPPLY CHAIN ANALYSIS 77
4.4 VALUE CHAIN ANALYSIS 78
4.5 BUSINESS STRATEGY EXCELLENCE 79
4.6 CASE STUDIES 80
4.7 STRENGTH OF PRODUCT PORTFOLIO 82
4.8 TECHNOLOGICAL TRENDS 84
4.9 PRICING ANALYSIS 85
5 INDUSTRY INSIGHTS 86
6 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS 87
7 MARKET OVERVIEW 89
7.1 DRIVERS 91
7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES 91
7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH 91
7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME 92
7.2 RESTRAINTS 93
7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES 93
7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME 93
7.3 OPPORTUNITIES 94
7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS. 94
7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY 94
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 95
7.4 CHALLENGES 96
7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS 96
7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES 96
8 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT 97
8.1 OVERVIEW 98
8.2 CONSUMABLES 101
8.2.1 KITS AND REAGENTS 102
8.2.1.1 EXOSOME BIOMARKER KITS 103
8.2.1.2 EXOSOME ISOLATION KITS 103
8.2.1.3 EXOSOME PURIFICATION KITS 103
8.2.1.4 EXOSOME QUANTITATIVE KITS 103
8.2.1.5 EXOSOME DETECTION KITS 103
8.2.1.6 OTHERS 103
8.2.2 EXOSOME STANDARDS 103
8.2.3 EXOSOME ANTIBODIES 103
8.2.4 CELL LINES 103
8.2.5 IMMUNOPLATES 104
8.2.6 IMMUNOBEADS 104
8.2.7 BIOFLUIDS 104
8.2.8 OTHERS 104
8.3 INSTRUMENTS 104
8.3.1 BENCHTOP 105
8.3.2 STANDALONE 105
9 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION 106
9.1 OVERVIEW 107
9.2 CANCER 110
9.2.1 LUNG CANCER 111
9.2.2 BREAST CANCER 111
9.2.3 COLORECTAL CANCER 111
9.2.4 PROSTATE CANCER 112
9.2.5 OTHER CANCER 112
9.3 NON-CANCER 112
9.3.1 CARDIOVASCULAR DISEASE 113
9.3.2 NEURODEGENERATIVE DISEASE 113
9.3.3 INFECTIOUS DISEASE 113
9.3.4 OTHERS 113
10 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION 114
10.1 OVERVIEW 115
10.2 THERAPEUTICS 118
10.3 CONSUMABLES 119
10.4 INSTRUMENTS 119
10.5 DIAGNOSIS 119
10.6 CONSUMABLES 120
10.7 INSTRUMENTS 120
11 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 121
11.1 OVERVIEW 122
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY 125
11.3 CONSUMABLES 126
11.4 INSTRUMENTS 126
11.5 RESEARCH CENTRES 126
11.6 CONSUMABLES 127
11.7 INSTRUMENTS 127
11.8 ACADEMIC INSTITUTES 127
11.9 CONSUMABLES 128
11.10 INSTRUMENTS 128
11.11 CLINICAL TESTING LABORATORY 128
11.12 CONSUMABLES 129
11.13 INSTRUMENTS 129
11.14 HOSPITALS 130
11.15 CONSUMABLES 131
11.16 INSTRUMENTS 131
11.17 OTHERS 131
12 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL 132
12.1 OVERVIEW 133
12.2 THIRD PARTY DISTRIBUTORS 136
12.3 DIRECT SALES 136
12.4 ONLINE 137
13 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY REGION 138
13.1 ASIA-PACIFIC 139
13.1.1 CHINA 149
13.1.2 JAPAN 155
13.1.3 INDIA 161
13.1.4 SOUTH KOREA 167
13.1.5 AUSTRALIA 173
13.1.6 SINGAPORE 179
13.1.7 MALAYSIA 185
13.1.8 THAILAND 191
13.1.9 INDONESIA 197
13.1.10 PHILIPPINES 203
13.1.11 NEW ZEALAND 209
13.1.12 VIETNAM 215
13.1.13 TAIWAN 221
13.1.14 REST OF ASIA-PACIFIC 227
14 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE 228
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 228
15 SWOT ANALYSIS 229
16 COMPANY PROFILE 230
16.1 THERMO FISHER SCIENTIFIC INC. 230
16.1.1 COMPANY SNAPSHOT 230
16.1.2 REVENUE ANALYSIS 230
16.1.3 COMPANY SHARE ANALYSIS 231
16.1.4 PRODUCT PORTFOLIO 231
16.1.5 RECENT DEVELOPMENT 232
16.2 EXODX (ACQUIRED BY BIO-TECHNE) 233
16.2.1 COMPANY SNAPSHOT 233
16.2.2 REVENUE ANALYSIS 233
16.2.3 COMPANY SHARE ANALYSIS 234
16.2.4 PRODUCT PORTFOLIO 234
16.2.5 RECENT DEVELOPMENT 234
16.3 MILTENYI BIOTEC 235
16.3.1 COMPANY SNAPSHOT 235
16.3.2 COMPANY SHARE ANALYSIS 235
16.3.3 PRODUCT PORTFOLIO 236
16.3.4 RECENT DEVELOPMENTS 236
16.4 LUMINEX CORPORATION 237
16.4.1 COMPANY SNAPSHOT 237
16.4.2 PRODUCT PORTFOLIO 237
16.4.3 RECENT DEVELOPMENT 237
16.5 HOLOGIC, INC. 238
16.5.1 COMPANY SNAPSHOT 238
16.5.2 REVENUE ANALYSIS 238
16.5.3 COMPANY SHARE ANALYSIS 239
16.5.4 PRODUCT PORTFOLIO 239
16.5.5 RECENT DEVELOPMENTS 239
16.6 AETHLON MEDICAL, INC. (2022) 240
16.6.1 COMPANY SNAPSHOT 240
16.6.2 PRODUCT PORTFOLIO 241
16.6.3 RECENT DEVELOPMENTS 241
16.7 AGILENT TECHNOLOGIES, INC. 242
16.7.1 COMPANY SNAPSHOT 242
16.7.2 REVENUE ANALYSIS 242
16.7.3 PRODUCT PORTFOLIO 243
16.7.4 RECENT DEVELOPMENT 243
16.8 AMSBI0 244
16.8.1 COMPANY SNAPSHOT 244
16.8.2 PRODUCT PORTFOLIO 244
16.8.3 RECENT DEVELOPMENT 244
16.9 AUDUBON BIOSCIENCE. 245
16.9.1 COMPANY SNAPSHOT 245
16.9.2 PRODUCT PORTFOLIO 245
16.9.3 RECENT DEVELOPMENT 245
16.10 BECKMAN COULTER, INC 246
16.10.1 COMPANY SNAPSHOT 246
16.10.2 PRODUCT PORTFOLIO 246
16.10.3 RECENT DEVELOPMENT 246
16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC) 247
16.11.1 COMPANY SNAPSHOT 247
16.11.2 REVENUE ANALYSIS 247
16.11.3 COMPANY SHARE ANALYSIS 248
16.11.4 PRODUCT PORTFOLIO 248
16.11.5 RECENT DEVELOPMENT 248
16.12 CELL GUIDANCE SYSTEMS LLC 249
16.12.1 COMPANY SNAPSHOT 249
16.12.2 PRODUCT PORTFOLIO 249
16.12.3 RECENT DEVELOPMENTS 249
16.13 CREATIVE BIOARRAY 250
16.13.1 COMPANY SNAPSHOT 250
16.13.2 PRODUCT PORTFOLIO 250
16.13.3 RECENT DEVELOPMENT 250
16.14 CUSABIO TECHNOLOGY LLC 251
16.14.1 COMPANY SNAPSHOT 251
16.14.2 PRODUCT PORTFOLIO 251
16.14.3 RECENT DEVELOPMENTS 251
16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION 252
16.15.1 COMPANY SNAPSHOT 252
16.15.2 REVENUE ANALYSIS 252
16.15.3 PRODUCT PORTFOLIO 253
16.15.4 RECENT DEVELOPMENT 253
16.16 HBMLS (ACQUIRED BY LONZA) 254
16.16.1 COMPANY SNAPSHOT 254
16.16.2 REVENUE ANALYSIS 254
16.16.3 PRODUCT PORTFOLIO 255
16.16.4 RECENT DEVELOPMENT 255
16.17 HITACHI, LTD. 256
16.17.1 COMPANY SNAPSHOT 256
16.17.2 REVENUE ANALYSIS 256
16.17.3 PRODUCT PORTFOLIO 257
16.17.4 RECENT DEVELOPMENT 257
16.18 INOVIQ 258
16.18.1 COMPANY SNAPSHOT 258
16.18.2 REVENUE ANALYSIS 258
16.18.3 PRODUCT PORTFOLIO 259
16.18.4 RECENT DEVELOPMENT 259
16.19 JSR MICRO NV 260
16.19.1 COMPANY SNAPSHOT 260
16.19.2 PRODUCT PORTFOLIO 260
16.19.3 RECENT DEVELOPMENT 260
16.20 MICROGENTAS 261
16.20.1 COMPANY SNAPSHOT 261
16.20.2 PRODUCT PORTFOLIO 261
16.20.3 RECENT DEVELOPMENTS 261
16.21 NANOSOMIX 262
16.21.1 COMPANY SNAPSHOT 262
16.21.2 PRODUCT PORTFOLIO 262
16.21.3 RECENT DEVELOPMENT 262
16.22 NEXOSOME-ONCOLOGY 263
16.22.1 COMPANY SNAPSHOT 263
16.22.2 PRODUCT PORTFOLIO 263
16.22.3 RECENT DEVELOPMENTS 263
16.23 NORGEN BIOTEK CORP. 264
16.23.1 COMPANY SNAPSHOT 264
16.23.2 PRODUCT PORTFOLIO 264
16.23.3 RECENT DEVELOPMENTS 264
16.24 NOVUS BIOLOGICALS 265
16.24.1 COMPANY SNAPSHOT 265
16.24.2 PRODUCT PORTFOLIO 265
16.24.3 RECENT DEVELOPMENT 266
16.25 PROTEOGENEX 267
16.25.1 COMPANY SNAPSHOT 267
16.25.2 PRODUCT PORTFOLIO 267
16.25.3 RECENT DEVELOPMENT 267
16.26 QIAGEN 268
16.26.1 COMPANY SNAPSHOT 268
16.26.2 REVENUE ANALYSIS 268
16.26.3 PRODUCT PORTFOLIO 269
16.26.4 RECENT DEVELOPMENT 269

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.